Shattuck Labs, Inc. (STTK)
NASDAQ: STTK · Real-Time Price · USD
6.10
+0.01 (0.16%)
At close: May 22, 2026, 4:00 PM EDT
5.35
-0.75 (-12.30%)
After-hours: May 22, 2026, 6:29 PM EDT
Shattuck Labs Revenue
In the year 2025, Shattuck Labs had annual revenue of $1.00M, down -82.52%.
Revenue (ttm)
$1.00M
Revenue Growth
-82.52%
P/S Ratio
467.75
Revenue / Employee
$25,000
Employees
40
Market Cap
467.75M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.00M | -4.72M | -82.52% |
| Dec 31, 2024 | 5.72M | 4.06M | 245.26% |
| Dec 31, 2023 | 1.66M | 1.01M | 154.14% |
| Dec 31, 2022 | 652.00K | -29.37M | -97.83% |
| Dec 31, 2021 | 30.02M | 20.08M | 202.16% |
| Dec 31, 2020 | 9.93M | 47.00K | 0.48% |
| Dec 31, 2019 | 9.89M | -12.56M | -55.94% |
| Dec 31, 2018 | 22.44M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| 4D Molecular Therapeutics | 88.24M |
| Prothena Corporation | 57.94M |
| vTv Therapeutics | 36.84M |
| Prelude Therapeutics | 16.72M |
| Adlai Nortye | 5.00M |
| Ocugen | 4.47M |
| Upstream Bio | 3.32M |
STTK News
- 15 days ago - Shattuck Labs Quarterly report: Q1 2026 - Filings
- 15 days ago - Shattuck Labs Earnings release: Q1 2026 - Filings
- 15 days ago - Shattuck Labs Slides: Corporate presentation - Filings
- 15 days ago - Shattuck Labs Reports First Quarter 2026 Financial Results and Recent Business Highlights - GlobeNewsWire
- 6 weeks ago - Shattuck Labs Proxy statement: Proxy filing - Filings
- 6 weeks ago - Shattuck Labs Proxy statement: Proxy filing - Filings
- 2 months ago - Shattuck Labs Slides: Corporate presentation - Filings
- 2 months ago - Shattuck Labs Annual report: Q4 2025 - Filings